You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 14, 2025

Drug Sales Trends for METHOTREXATE


✉ Email this page to a colleague

« Back to Dashboard


Payment Methods and Pharmacy Types for METHOTREXATE (2021)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $12,763,076
INSIDE ANOTHER STORE $25,900,977
[disabled in preview] $128,137,766
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 603,574
INSIDE ANOTHER STORE 934,751
[disabled in preview] 2,863,993
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $12,416,988
MEDICARE $53,224,596
[disabled in preview] $101,160,235
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for METHOTREXATE
Drug Units Sold Trends for METHOTREXATE

Annual Sales Revenues and Units Sold for METHOTREXATE

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
METHOTREXATE ⤷  Try for Free ⤷  Try for Free 2021
METHOTREXATE ⤷  Try for Free ⤷  Try for Free 2020
METHOTREXATE ⤷  Try for Free ⤷  Try for Free 2019
METHOTREXATE ⤷  Try for Free ⤷  Try for Free 2018
METHOTREXATE ⤷  Try for Free ⤷  Try for Free 2017
>Drug Name >Revenues (USD) >Units >Year

Methotrexate Drugs Market: A Comprehensive Analysis and Sales Projections

Introduction to Methotrexate

Methotrexate is a widely used medication for treating various medical conditions, including autoimmune diseases such as rheumatoid arthritis, psoriasis, and certain types of cancer. Its versatility and effectiveness have made it a cornerstone in modern medicine.

Global Methotrexate Drugs Market Size and Forecast

The global methotrexate drugs market is experiencing significant growth, driven by increasing demand for treatments of autoimmune diseases and cancer. As of 2024, the market size was valued at approximately USD 584.09 million and is projected to exceed USD 846.99 million by 2037, with a Compound Annual Growth Rate (CAGR) of over 2.9% during the forecast period of 2025-2037[1].

Key Drivers of the Methotrexate Market

Increasing Prevalence of Autoimmune Diseases

The rising prevalence of autoimmune diseases such as rheumatoid arthritis, psoriasis, and lupus is a major driver of the methotrexate market. For instance, around 60% of people with rheumatoid arthritis are currently taking methotrexate, which is the recommended first-line treatment according to the American College of Rheumatology[1].

Growing Incidence of Cancer

Methotrexate is also widely used in cancer treatment, particularly for slowing down the growth of cancer cells. The segment is expected to hold significant revenue share due to the rising incidence rates of various types of cancers globally. For example, prostate, lung, and colorectal cancers account for a substantial percentage of all cancer diagnoses[1].

Regulatory Approvals and Innovations

The increasing number of drug approvals by regulatory bodies is another key driver. For example, the submission of a New Drug Submission for a methotrexate auto-injector by NORDIC PHARMA in 2022 highlights the ongoing innovation in this market[2].

Technological Advancements and Personalized Medicine

Advancements in technology and the demand for personalized medicine are also fostering market growth. These advancements include the development of new formulations such as prefilled syringes and generic tablets, which enhance patient compliance and ease of use[3].

Market Segmentation

By Indication

The methotrexate market is segmented by indication into autoimmune diseases (rheumatoid arthritis, psoriasis, lupus) and cancer. The cancer segment is expected to grow significantly due to the higher usage of methotrexate in cancer treatment compared to other indications[1].

By Drug Type and Form

The market is also segmented by drug type and form, including oral, subcutaneous, intramuscular, and intravenous routes of administration. The oral segment, particularly tablets, is expected to dominate due to convenience, accurate dosage, and cost-effectiveness[3].

By Distribution Channel

The distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies. Hospital pharmacies are expected to garner a significant share due to the increasing influx of patients seeking treatment for target diseases[3].

Regional Analysis

North America

The North American methotrexate drugs market is projected to hold a significant revenue share, estimated at around 41% by 2037. This is driven by high healthcare expenditures, the adoption of innovative technologies, and supportive reimbursement policies in the region[1].

Asia-Pacific

The Asia-Pacific region is expected to experience notable growth due to increasing awareness of different medical modalities and a surging number of patients requiring medical treatments, including those for autoimmune diseases and cancer[1].

Europe and Other Regions

Regions like the UK, Japan, and Saudi Arabia are also expected to see significant and promising growth from 2024 to 2032, driven by similar factors such as rising disease prevalence and advancements in healthcare infrastructure[3].

End-User Analysis

Hospitals

The hospital segment is expected to grow with the highest CAGR of 3.3% during the forecast period. This is due to the increasing number of patients seeking treatment at hospitals, particularly for chemotherapy and other severe conditions[1].

Specialty Clinics and Home Healthcare

Specialty clinics and home healthcare segments are also expected to grow significantly as patients seek more convenient and specialized care options[1].

Challenges and Opportunities

Challenges

Despite the growth, the methotrexate market faces challenges such as side effects associated with the drug, competition from alternative treatments, and regulatory hurdles. Manufacturers must focus on reducing these challenges through innovative formulations and better patient education[3].

Opportunities

The market presents several opportunities, including the development of new drug formulations, expansion into emerging markets, and increasing investments in research and development. For instance, the launch of new products like prefilled syringes and generic tablets offers significant growth potential[2].

Key Takeaways

  • The global methotrexate drugs market is projected to grow significantly, driven by increasing demand for treatments of autoimmune diseases and cancer.
  • The market is expected to exceed USD 846.99 million by 2037, with a CAGR of over 2.9% during the forecast period.
  • North America and the Asia-Pacific region are expected to be key contributors to market growth.
  • Hospital pharmacies and specialty clinics will play crucial roles in the distribution and administration of methotrexate.
  • Innovations in drug formulations and technological advancements will continue to drive market growth.

FAQs

What is the current size of the global methotrexate drugs market?

The global methotrexate drugs market was valued at approximately USD 584.09 million in 2024[1].

What is the projected growth rate of the methotrexate market?

The market is expected to grow at a CAGR of over 2.9% from 2025 to 2037[1].

Which segment is expected to dominate the methotrexate market?

The oral segment, particularly tablets, is expected to dominate due to convenience, accurate dosage, and cost-effectiveness[3].

What are the key drivers of the methotrexate market?

Key drivers include the increasing prevalence of autoimmune diseases, growing incidence of cancer, regulatory approvals, and technological advancements[1][2][3].

Which regions are expected to see significant growth in the methotrexate market?

North America and the Asia-Pacific region are expected to be key contributors to market growth, along with regions like the UK, Japan, and Saudi Arabia[1][3].

Sources

  1. Research Nester, "Methotrexate Drugs Market Size & Share, Forecast Report 2037"
  2. Coherent Market Insights, "Methotrexate Drugs Market Size, Trends and Forecast to 2030"
  3. Global Market Insights, "Methotrexate Drugs Market Size & Share Report, 2024 – 2032"
  4. Research Nester, "Methotrexate Market Size, Forecast Report 2037"
  5. Industry Research Biz, "Methotrexate Market: Analysis, Trends, and Projections for 2024-2032"
Last updated: 2024-12-31

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.